The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / 8 Ways to Help Your Patients with Medication Costs

8 Ways to Help Your Patients with Medication Costs

October 18, 2018 • By Vanessa Caceres

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Sherry Yates Young / shutterstock.com

Sherry Yates Young / shutterstock.com

A patient with rheumatoid arthritis (RA) comes to your office and needs a medication. You prescribe it, and the patient’s insurance plan covers it. The patient begins the medication and slowly but surely feels better.

You Might Also Like
  • Eli Lilly Backs U.S. Proposal on Drug Rebates to Lower Costs
  • Can Anything Contain Drug Costs in the U.S.?
  • Trump Administration Proposes Medicare Rules Aimed at Opioids, Drug Costs
Explore This Issue
October 2018
Also By This Author
  • Trial Pits Upadacitinib vs. Adalimumab for Psoriatic Arthritis

Prescribing drugs for a patient should be this simple but rarely is, thanks to the high cost of drugs and the variance in what insurance plans or Medicare cover.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Rheumatologists face questions about drug costs every day, and they are not always easy to answer. “Not infrequently, patients will ask if a drug is covered by their formulary,” says Allan Gibofsky, MD, Hospital for Special Surgery, and professor of medicine, Weill Cornell Medical College, New York. “When I make a drug decision, I may find out from the patient or staff that the drug is not covered, and we then look to prescribe something else. Sometimes that’s acceptable; sometimes it’s problematic, and we have to go through the appeals process.”

Drug-cost questions are particularly common for branded and newer drugs that treat RA, psoriatic arthritis and lupus, says Jonathan Greer, MD, president, Arthritis and Rheumatology Associates of Palm Beach, Palm Beach Gardens, Fla. However, even traditionally lower cost disease-modifying anti-rheumatic drugs (DMARDs) have had recent price increases and shortages, says Elizabeth Perkins, MD, Rheumatology Care Center, Birmingham, Ala.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Private insurance and Medicare patients each come with their own drug-cost issues that rheumatology practices must analyze and help manage.

The maze of prior authorization, insurance formularies and ever-changing drug costs has led rheumatologists to dedicate staff members to research the issue and keep patients up to date. It’s also led to frustration when rheumatologists get caught in the middle. Dr. Greer has had patients lash out at him when they haven’t received their medication. He checks in with staff, only to find out the prescription is still in process with the insurance company. “It’s very challenging,” he says.

The need for prior authorizations—and the paperwork and time they involve—has become more common in Dr. Greer’s experience.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

The entry of biosimilars into the drug market adds a viable, but not always straightforward, option to lower drug costs, rheumatologists say. “So far, two infliximab biosimilars are available to rheumatologists, and they offer about a 15% discount compared with the bio-originator drug, Remicade,” says Angus B. Worthing, MD, FACP, FACR, Arthritis & Rheumatism Associates in the Washington, D.C., area, and chair of the ACR’s Government Affairs Committee. “It’s not clear that insurers are passing that savings on to patients, and some aren’t even covering the biosimilar. Clearly, we have a long way to go before patients realize savings.”

Pages: 1 2 3 4 5 | Single Page

Filed Under: Drug Updates, Patient Perspective, Practice Management Tagged With: cost saving, drug costsIssue: October 2018

You Might Also Like:
  • Eli Lilly Backs U.S. Proposal on Drug Rebates to Lower Costs
  • Can Anything Contain Drug Costs in the U.S.?
  • Trump Administration Proposes Medicare Rules Aimed at Opioids, Drug Costs
  • Rheumatologists Concerned High Healthcare Costs May Encourage Patients to Forgo, Delay Treatment

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)